Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：119
|
作者：
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
机构：
[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan
[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan
[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan
[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 01期
关键词：
CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;
D O I：
10.1097/00008571-200002000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 89
页数：5
相关论文
共 50 条
  • [31] Roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone
    Matsumoto, Kaori
    Hasegawa, Tetsuya
    Ohara, Kosuke
    Takei, Chihiro
    Akimoto, Masayuki
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2020, 50 (01) : 71 - 79
  • [32] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    A. Yu. Sambyalova
    T. A. Bairova
    E. V. Belyaeva
    O. A. Ershova
    D. S. Sargaeva
    S. I. Kolesnikov
    Russian Journal of Genetics, 2020, 56 : 1496 - 1503
  • [33] CYP2C9, CYP4F2, VKORC1 Gene Polymorphism in Buryat Population
    Sambyalova, A. Yu.
    Bairova, T. A.
    Belyaeva, E. V.
    Ershova, O. A.
    Sargaeva, D. S.
    Kolesnikov, S. I.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (12) : 1496 - 1503
  • [34] Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations
    Cho, Myung-A
    Yoon, Jihoon G.
    Kim, Vitchan
    Kim, Harim
    Lee, Rowoon
    Lee, Min Goo
    Kim, Donghak
    BIOMOLECULES & THERAPEUTICS, 2019, 27 (06) : 577 - 583
  • [35] CYP2C9 and CYP2C19 genetic polymorphisms:: frequencies in the south Indian population
    Jose, R
    Chandrasekaran, A
    Sam, SS
    Gerard, N
    Chanolean, S
    Abraham, BK
    Satyanarayanamoorthy, K
    Peter, A
    Rajagopal, K
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (01) : 101 - 105
  • [36] Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis
    Aithal, GP
    Day, CP
    Leathart, JBS
    Daly, AK
    PHARMACOGENETICS, 2000, 10 (06): : 511 - 518
  • [37] CYP2C9 Genetic Polymorphism is a Potential Predictive Marker for the Efficacy of Rosuvastatin Therapy
    Lin, Jiayao
    Zhang, Yu
    Zhou, Houguang
    Wang, Xinqing
    Wang, Wenwen
    CLINICAL LABORATORY, 2015, 61 (09) : 1317 - 1324
  • [38] Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects
    Huang, Hang-Xing
    Wu, He
    Zhao, Yingying
    Zhou, Tao
    Ai, Xin
    Dong, Yu
    Zhang, Yan
    Lai, Yong
    XENOBIOTICA, 2021, 51 (05) : 616 - 623
  • [39] Early overanticoagulation with acenocournarol due to a genetic polymorphism of cytochrorne P450CYP2C9
    André-Kerneïs, E
    Leroy-Matheron, C
    Gouault-Heilmann, M
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) : 761 - 764
  • [40] Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region
    Varshney, Ekta
    Saha, Nilanjan
    Tandon, Monika
    Shrivastava, Vikesh
    Ali, Shakir
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2013, 38 (04) : 275 - 282
12345